Christopher L. Jacobs disclosed buy in Relmada Therapeutics, Inc.
Christopher L. Jacobs disclosed buy activity in Relmada Therapeutics, Inc..
Signal
Congress Trade
Action
Buy
Capital
$1,001 - $15,000
Why it matters
Congress disclosures can highlight policy-adjacent trading activity. This card is generated from canonical action facts, not request-time scraping.